LatchBio β’ 268 implied HN points β’ 07 Mar 24
- Elsie Biotechnologies uses computational design tools and high-throughput experimental approaches to develop drugs.
- Partnerships with large pharmaceutical companies like GSK can significantly impact the progress of smaller biotech companies.
- Oligonucleotide therapies represent the future of drug development, promising safer and more effective treatments.